18:47 , Nov 16, 2016 |  BC Extra  |  Financial News

Glycomine raises $12M in series A round

Rare disease company Glycomine Inc. (San Francisco, Calif.) raised $12 million in a series A round led by Sanderling Ventures and Chiesi Ventures. The company's preclinical lead program is substrate replacement therapy Lipo-M1P to treat congenital...